Literature DB >> 30905893

Long Noncoding RNA LINC00202 Promotes Tumor Progression by Sponging miR-3619-5p in Retinoblastoma.

Guigang Yan1, Yi Su2, Zhao Ma2, Lianzhi Yu3, Ning Chen1.   

Abstract

Retinoblastoma (RB) is the most common intraocular malignancy in childhood, and the prognosis in the advanced RB is poor. It is urgent to find novel therapeutic targets. Long noncoding RNAs (lncRNAs) have critical functions in cancer progression, and lncRNA LINC00202 is found associated with poor prognosis in RB. However, the functions of LINC00202 in RB remain unclear. We employed qRT-PCR and immunoblot to detect the expression levels of mRNAs and proteins, respectively. Cell proliferation was determined by CCK-8 assay and colony formation assay. Transwell assays were applied to evaluate the cell abilities of migration and invasion. Luciferase reporter assay was applied to examine RNA stability, and RNA pulldown assays were used to detect interaction between lncRNA and microRNA (miRNA). LINC00202 expression in RB tissues is higher than that in the paired adjacent normal tissues, which has correlation with poor prognosis in RB. RB cell proliferation, migration and invasion were weakened by LINC00202 depletion, but enhanced by LINC00202 overexpression. MiR-3619-5p was identified to directly bind and mediate LINC00202-promoted RB progression, meanwhile, miR-3619-5p directly regulated expression of an oncongene, RIN1. Moreover, RIN1 knockdown completely blocked miR-3619-5p-enhanced RB progression. In summary, high LINC00202 levels are correlated with poor prognosis in RB, and it promotes RB progression by sponging miR-3619-5p and therefore up-regulating RIN1 expression.Key words: LINC00202, miR-3619-5p, retinoblastoma, progression, RIN1.

Entities:  

Keywords:  LINC00202; RIN1; miR-3619-5p; progression; retinoblastoma

Mesh:

Substances:

Year:  2019        PMID: 30905893     DOI: 10.1247/csf.18033

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  12 in total

1.  The lncRNA-DLEU2/miR-186-5p/PDK3 axis promotes the progress of glioma cells.

Authors:  Zuochang Xie; Xiaojian Li; Hua Chen; Ailiang Zeng; Yan Shi; Yong Tang
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

2.  STAT4-mediated down-regulation of miR-3619-5p facilitates stomach adenocarcinoma by modulating TBC1D10B.

Authors:  Yinhua Liu; Jiaping Li; Sufeng Wang; Hong Song; Tao Yu
Journal:  Cancer Biol Ther       Date:  2020-05-13       Impact factor: 4.742

3.  LINC00511 promotes gastric cancer cell growth by acting as a ceRNA.

Authors:  Chong-Bing Sun; Hong-Yi Wang; Xiao-Qing Han; Yong-Ning Liu; Meng-Chun Wang; Hong-Xia Zhang; You-Feng Gu; Xiao-Gang Leng
Journal:  World J Gastrointest Oncol       Date:  2020-04-15

4.  M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.

Authors:  Xueliang Zuo; Zhiqiang Chen; Wen Gao; Yao Zhang; Jinguo Wang; Junfeng Wang; Ming Cao; Juan Cai; Jindao Wu; Xuehao Wang
Journal:  J Hematol Oncol       Date:  2020-01-08       Impact factor: 17.388

5.  Downregulation of LINC00958 inhibits proliferation, invasion and migration, and promotes apoptosis of colorectal cancer cells by targeting miR‑3619‑5p.

Authors:  Ye Sun; Yi Liu; Yun Cai; Pingping Han; Rui Wang; Lijun Cao; Shuixiang He
Journal:  Oncol Rep       Date:  2020-07-29       Impact factor: 3.906

6.  LINC00202 promotes retinoblastoma progression by regulating cell proliferation, apoptosis, and aerobic glycolysis through miR-204-5p/HMGCR axis.

Authors:  Aimin Wu; Xuewei Zhou; Linglong Mi; Jiang Shen
Journal:  Open Life Sci       Date:  2020-06-30       Impact factor: 0.938

7.  lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p.

Authors:  Yuxin Zhao; Zhaoxia Wang; Meili Gao; Xuehong Wang; Hui Feng; Yuanyuan Cui; Xia Tian
Journal:  Open Med (Wars)       Date:  2021-06-24

Review 8.  Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis.

Authors:  Jiali Wu; Dashi Qian; Xiaodong Sun
Journal:  Cancer Cell Int       Date:  2020-05-29       Impact factor: 5.722

9.  Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.

Authors:  Qian Zhou; Juan Guo; Wenjie Huang; Xiaosi Yu; Chen Xu; Xinghua Long
Journal:  Mol Oncol       Date:  2020-05-24       Impact factor: 6.603

10.  Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.

Authors:  Xiaowen Sun; Hui Shen; Shubin Liu; Jing Gao; Shuyan Zhang
Journal:  Int J Mol Med       Date:  2020-03-20       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.